Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119985) titled 'ClinicaApplication of NALIRIFOX-Based Total Neoadjuvant Therapy in Patients with Locally Advanced Pancreatic Cancer' on March 6.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital of Sichuan University

Condition: locally advanced pancreatic cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-01

Target Sample Size: Neoadjuvant therapy group:36;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=305842

Published by HT Digital Content Services with permission from Health Daily D...